Induction of Differentiation of Human Myeloid Cell Lines by Tumor Necrosis Factor in Cooperation with 1α, 25-Dihydroxyvitamin D3

Cancer Research

Volumn 47, Issue 9, 1987, Pages 2236-2242

  Trinchieri, Giorgio ^a   Rosen, Mark ^a   Perussia, Bice ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; GAMMA INTERFERON; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR;

BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINE; DRUG COMPARISON; DRUG EFFICACY; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL;

CALCITRIOL; CELL DIFFERENTIATION; CELL LINE; DRUG SYNERGISM; GLYCOPROTEINS; HUMAN; LEUKEMIA, MYELOCYTIC, ACUTE; PHENOTYPE; RECEPTORS, FC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURFACE PROPERTIES; TUMOR NECROSIS FACTOR;

EID: 0023199362     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Gallagher, R., Collins, R., Trujill, J., McCredie, K., Ahearn, M., Tsai, S., Metzgar, R., Aulak, G., Ting, R., Ruscetti, F., and Gallo, R. Characterization of the continuous differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood, 54:713-733, 1979.
2. Palumbo, A., Minowada, J., Erikson, J., Croce, C. M., and Rovera, G. Lineage infidelity of a human leukemia cell line. Blood, 64: 1059–1063, 1984.
3. Sundstrom, C., and Vilsson, K. Establishment and characterization of a human histiocytic cell line (U937). Int. J. Cancer, 17:565-577, 1976.
4. Collins, S. J., Ruscetti, M. W., Gallagher, R. E., and Gallo, R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA, 75:2458-2462, 1978.
5. Breitman, T. R., Selonick, S. E., and Collins, S. J. Induction of differentiation of the human promyelocytic cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA, 77: 2936-2940, 1980.
6. Rovera, G., Santoli, D., and Damsky, C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with phorbol diesters. Proc. Natl. Acad. Sci. USA, 76:2779-2783, 1979.
7. Miyaura, C., Abe, E., Kuribayashi, T., Tanaka, H., Kouno, K., Nishii, Y., and Suda, T. 1-25, Dihydroxy vitamin D3 induces differentiation of human myeloid cells. Biochem. Biophys. Res. Commun., 102:937-943, 1981.
8. Elias, L., Wogenrich, F. J., Wallace, J. M., and Longmire, J. Altered pattern of differentiation and proliferation of HL-60 promyelocytic leukemia cells in the presence of leucocyte conditioned medium. Leukemia Res., 4: 301–307, 1980.
9. Mangelsdorf, D. J., Koeffer, H. P., Donaldson, C. A., Pike, J. W., and Haussler, M. R. 1, 25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J. Cell. Biol., 98:391-398, 1984.
10. Olsson, I., Gullberg, U., Ihved, 1., and Nilsson, K. Induction of differentiation of the human histiocytic lymphoma cell line U937 by 1, 25-dihydroxylcholecalcitriol. Cancer Res., 43:5862-5867, 1983.
11. Rigby, W. F. C., Shen, L., Ball, E. D., and Fanger, M. W. 1, 25-Dihydroxy-vitamin D3induces a myelomonocytic phenotype with enhanced effector cell function in the HL-60 promyelocytic leukemia cell line. Mol. Immunol., 22: 567-572, 1985.
12. Perussia, B., Dayton, E. T., Fanning, V., Thiagarajan, P., Hoxie, J., and Trinchieri, G. Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway. J. Exp. Med., 158:2058-2080, 1983.
13. Perussia, B., Dayton, E. T., Lazarus, R., Fanning, V., and Trinchieri, G. Immune interferon induces the receptor for monomeric IgGl on human monocytic and myeloid cells. J. Exp. Med., 158: 1092-1113, 1983.
14. Ball, E. D., Guyre, P. M., Shen, L., Glynn, J. M., Maliszewski, C. R., Baker, P. E., and Fanger, M. W. Gamma interferon induces monocytoid differentiation in the HL-60 cell line. J. Clin. Invest., 73:1072-1077, 1984.
15. Ralph, P., Harris, P. E., Punjabi, C. J., Welte, K., Litcofsky, P. B., Ho, M-K., Rubin, B. Y., Moore, M. A. S., and Springer, T. A. Lympholdne inducing “terminal differentiation” of the human monoblast leukemia line U937: a role for γ-interferon. Blood, 62: 1169-1175, 1983.
16. Dayton, E. T., Matsumoto-Kobayashi, M., Perussia, B., and Trinchieri, G. Role of immune interferon in the monocytic differentiation of human promyelocytic cell lines induced by leukocyte conditioned medium. Blood, 66: 583-594, 1985.
17. Harris, P. E., Ralph, P., Gabrilove, J., Welte, K., Karmali, R., and Moore, M. A. S. Distinct differentiation-inducing activities of 7-interferon and cytokine factors acting on the human promyelocytic leukemia cell line HL-60. Cancer Res., 45:3090-3095, 1985.
18. Guyre, P. M., Morganelli, P. M., and Miller, R. Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. J. Clin. Invest., 72:393-397, 1983.
19. Basham, T. Y., and Merigan, T. C. Recombinant interferon-7 increases HLA-DR synthesis and expression. J. Immunol., 130:1492-1497, 1983.
20. Gullberg, U., Nilsson, E., Einhorn, S., and Olsson, I. Combinations of interferon-7 and retinoic acid or 1α, 25-dihydroxycholecalciferol induce differentiation of the human monoblast leukemia cell line U937. Exp. Hematol., 13:675-679, 1985.
21. Weinberg, J. B., Misukonis, M. A., Hobbs, M. H., and Borowitz, M. J. Cooperative effects of γ-interferon and 1, 25-dihydroxyvitamin D3 in inducing differentiation of human promyelocytic leukemia (HL-60) cells. Exp. Hem-atol., 14:138-142, 1986.
22. Morel, P. A., Manolagas, S. C., Provvedini, D. M., Wegmann, D. R., and Chiller, J. M. lnterferon-γ-induced Ia expression in WEHI-3 cells is enhanced by the presence of 1, 25-dihydroxyvitamin D3. J. Immunol., 136: 2181-2186, 1986.
23. Koeffler, H. P., Reichel, H., Bishop, J. E., and Norman, A. W. γ-lnterferon stimulates production of 1, 25-dihydroxyvitamin D3by normal human macrophages. Biochem. Biophys. Res. Commun., 127:596-603, 1985.
24. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., and Williamson, B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA, 72:3666-3670, 1975.
25. Ruddle, N. H., and Waksman, B. W. Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. III. Analysis of mechanism. J. Exp. Med., 128:1267-1279, 1968.
26. Williams, T. W., and Granger, G. A. Lymphocyte in vitro cytotoxicity: lymphotoxin of several mammalian species. Nature (Lond.), 219: 1076-1077, 1968.
27. Williams, T. W., and Bellanti, J. A. In vitro synergism between interferons and human lymphotoxin: enhancement of lymphotoxin-induced target cell killing. J. Immunol., 130: 518-520, 1983.
28. Stone-Wolff, D. S., Yip, Y. K., Kelker, H. C., Le, J., Henriksen-Destefano, D., Rubin, B. Y., Rinderknecht, E., Aggarwal, B. B., and Vilcek, J. Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin. J. Exp. Med., 159:828-843, 1984.
29. Aggarwal, B. B., Moffat, B., and Harkins, R. N. Human lymphotoxin production by a lymphoblastoid cell line; purification and initial characterization. J. Biol. Chem., 259:686-691, 1984.
30. Aggarwal, B., Henzel, W., Moffat, B., Kohr, W., and Harkins, R. N. Primary structure of human lymphotoxin derived from 1788 lymphoblastoid cell line. J. Biol. Chem., 260:2334-2338, 1985.
31. Gray, P. W., Aggarwal, B. B., Benton, C. V., Bringman, T. S., Henzel, W. J., Jarrett, J. A., Leung, D. W., Moffat, B., Ng, P., Svedersky, L. P., Palladino, M. A., and Nedwin, G. E. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumor necrosis activity. Nature (Lond.), 312:721-724, 1984.
32. Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., and Goeddel, D. V. Human tumor necrosis factor precursor structure, expression and homology to lymphotoxin. Nature (Lond.), 312:724-729, 1984.
33. Wang, A. M., Creasy, A. A., Ladner, M. B., Lin, L. S., Strickler, J., Van Arsdell, J. N., Yamamoto, R., and Mark, D. F. Molecular cloning of the complementary DNA for human tumor necrosis factor. Science (Wash.), 228:149-154, 1985.
34. Sugarman, B. J., Aggarwal, B. B., Hass, P. E., Figari, I. S., Palladino, M. A., and Shepard, H. M. Recombinant human tumor necrosis factor-a: effects on proliferation of normal and transformed cells in vitro. Science (Wash.), 230:943-945, 1985.
35. Vilcek, J., Palombella, V. J., Henriksen-Destefano, D., Swenson, C., Fein-man, R., Hirai, M., and Tsujmoto, M. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J. Exp. Med., 163:632-643, 1986.
36. Trinchieri, G., Kobayashi, M., Murphy, M., and Perussia, B. Immune interferon and cytotoxins: regulatory effects on myeloid cells. Lymphokines, in press, 1987.
37. Trinchieri, G., Kobayashi, M., Rosen, M., Loudon, R., Murphy, M., and Perussia, B. Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cells in synergy with immune interferon. J. Exp. Med., 164:1206-1225, 1986.
38. Breard, J., Reinherz, E. L., Kung, P. C., Goldstein, G., and Schlossman, S. F. A monoclonal antibody reactive with human peripheral blood monocytes. J. Immunol., 124:1943-1948, 1980.
39. Dayton, E. T., Perussia, B., and Trinchieri, G. Correlation between differentiation, expression of monocyte-specific antigens, and cytotoxic functions in human promyelocytic cell lines treated with leukocyte-conditioned medium. J. Immunol., 130:1120-1128, 1983.
40. Todd, R. F., Ill, Griffin, J. D., Ritz, J., Nadler, L. M., Abrams, T., and Schlossman, S. F. Expression of normal monocyte-macrophage differentiation antigens on HL-60 promyelocytes undergoing differentiation induced by leukocyte conditioned medium or phorbol diester. Leukemia Res., 5: 491-495.1981.
41. Todd, R. F., III, Nadler, L. M., and Schlossman, S. F. Antigens on human monocytes identified by monoclonal antibodies. J. Immunol., 126: 1435-1442, 1981.
42. Perussia, B., Acuto, O., Terhorst, C., Faust, S., Lazarus, R., Fanning, V., and Trinchieri, G. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc-receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane. J. Immunol., 130: 2142–2148, 1983.
43. Haynes, B. F., Hemler, M. E., Mann, D. L., Eisenbarth, G. S., Shelhamer, J., Mostowski, H. S., Thomas, C. A., Strominger, J. L., and Fauci, A. S. Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J. Immunol., 126:1409-1414, 1981.
44. Fleit, H. B., Wright, S. D., and Unkeless, J. C. Human neutrophil Fc receptor distribution and structure. Proc. Natl. Acad. Sci. USA, 79:3275-3279, 1982.
45. Vaughn, M., Tayler, M., and Mohanakamur, T. Characterization of human IgG Fc receptors. J. Immunol., 135:4059-4065, 1985.
46. Platt, W. R. Color Atlas and Textbook of Hematology, p. 518. Philadelphia: J. B. Lippincott Co., 1979.
47. Trinchieri, G., de Marchi, M., Mayr, W., Savi, M., and Ceppellini, R. Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HLA. Transplant. Proc., 5:1631-1646, 1973.
48. Nedwin, G. E., Svedersky, L. P., Bringman, T. S., Palladino, M. A., and Goeddel, D. V. Effect of interleukin 2, interferon and mitogens on the production of tumor necrosis factors α and β. J. Immunol., 135:2492-2497, 1985.
49. Amento, E. P., Bhalia, A. K., Kurnick, J. T., Kadrin, R. L., Clemens, J. L., Holick, S. A., Holick, M. F., and Krane, S. M. 1, 25-Dihydroxyvitamin D3induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J. Clin. Invest, 73:731-739, 1984.
50. Murphy, M., Loudon, R., Kobayashi, M., and Trinchieri, G. Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte-monocyte colony formation. J. Exp. Med., 164:263-279, 1986.
51. Bertolini, D. R., Nedwin, N. G., Bringman, T., Smith, D., and Mundy, G. R. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature (Lond.), 319:516-518, 1986.
52. Dodd, R. C., Newman, S. L., Bunn, P. A., Winkler, C. F., Cohen, M. S., and Gray, T. K. Lymphokine-induced monocytic differentiation as a possible mechanism for hypercalcemia associated with T-cell lymphoma. Cancer Res., 45:2501-2506, 1985.
53. Conta, B. S., Powell, M. B., and Ruddle, N. H. Activation of Lyt-1+ and Lyt-2+ T T cell cloned lines: stimulation of proliferation, lymphokine production, and self destruction. J. Immunol., 134:2185-2190, 1985.
54. Cuturi, M. C., Murphy, M., Costa-Giomi, M. P., Weinmann, R., Perussia, B., and Trindrieri, G. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J. Exp. Med., in press, 1987.
55. Gkonos, P. I., Loudon, R., and Hendler, E. D. Hypercalcemia and elevated 1, 25-dihydroxyvitamin D levels in a patient with end stage renal disease and active tuberculosis. N. Engl. J. Med., 311:1683-1685, 1984.